INNOVO is Clinically Proven to Treat Bladder Weakness
A 26-week pilot study of women with stress urinary incontinence who followed the INNOVO treatment regimen for 12 weeks found significant improvement in their symptoms:
- An improvement in the amount of involuntary urine leaked over 1 hour in 93% of INNOVO users after 4 weeks of treatment, where 60% were defined as dry1
![](https://cdn.shopify.com/s/files/1/0594/4308/5486/files/1h-stress-test-chart.jpg?v=1637938709)
- An average74% reduction in involuntary urine loss over 24 hours after 12 weeks of treatment, where 86% of INNOVO users were defined as dry or almost dry2
![](https://cdn.shopify.com/s/files/1/0594/4308/5486/files/24h-stress-test-chart.jpg?v=1637938765)
- An improvement in the Modified Oxford Score (standing position) after treatment with INNOVO,where 79% of patients had good or moderate pelvic floor muscle contractions at 12 weeks, compared with 6% at baseline1
![](https://cdn.shopify.com/s/files/1/0594/4308/5486/files/figure-4.jpg?v=1637938796)
Patients’ pelvic floor muscle contractility improved over 12 weeks of INNOVO treatment